Healthcare professional payments
At LEO Pharma UK/IE, we are proud of the ethical and transparent culture that is embedded across our organisation and expressed in our values.
We take compliance very seriously and we ensure we apply the principles and adhere to the requirements of the Association of British Pharmaceutical Industry (ABPI) and the Irish Pharmaceutical and Healthcare Association (IPHA) Codes of Practice in everything we do.
LEO Pharma recognises and supports increased transparency as an important means of demonstrating integrity of the pharmaceutical industry and as an aid to build and maintain the trust of the general public and healthcare professionals.
In line with the above, LEO Pharma UK/IE welcomes the disclosure of transfers of value (TOV) to Healthcare Professionals (HCPs), Healthcare Organisations (HCOs) and Other Relevant Decision Makers (ORDMs).
Due to the COVID-19 outbreak, the ABPI has agreed that the 2019 disclosures will be published in aggregate format only on their website and named individual level HCP/HCO payments will be published at a later date. In order to be as transparent as possible, LEO Pharma UK/IE will temporarily disclose named individual level HCP/HCO payments below together with the accompanying Methodological note. This data will be posted on the ABPI website as soon as it is appropriate to do so. This information can be found here.